Literature DB >> 29344092

Engaging the primary care community to encourage appropriate prostate cancer screening.

Malhar P Patel1, Ariel Schulman2, Kevin P Shah3, John B Anderson3, Thomas J Polascik2.   

Abstract

Prostate-specific antigen (PSA) screening for prostate cancer remains a controversial topic, particularly in the primary care community. Our multidisciplinary prostate screening panel at Duke University Health System, USA created a nuanced PSA screening algorithm, implemented it into the Electronic Health Record of Duke Primary Care, and conducted outreach meetings with primary care practices to support its rollout. Through this project, we identified areas of concern among primary care clinicians regarding PSA screening that we structured into two major categories: ideological opposition and logistical opposition. We outlined specific concerns in each major category and described how our team responded to those concerns. As communication between primary care clinicians and prostate specialists is vital to the success and safety of PSA screening programs, we hope that describing primary care concerns and our responses to them will help other health systems thoughtfully and efficiently implement appropriate PSA screening programs moving forward.

Entities:  

Keywords:  PSA screening; multidisciplinary; primary care; prostate cancer screening

Year:  2017        PMID: 29344092      PMCID: PMC5761916          DOI: 10.1177/1756287217735799

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN: 1756-2872


  24 in total

1.  Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations.

Authors:  Michael E Zavaski; Christian P Meyer; Jesse D Sammon; Julian Hanske; Soham Gupta; Maxine Sun; Quoc-Dien Trinh
Journal:  JAMA Intern Med       Date:  2016-04       Impact factor: 21.873

2.  Early detection of prostate cancer: AUA Guideline.

Authors:  H Ballentine Carter; Peter C Albertsen; Michael J Barry; Ruth Etzioni; Stephen J Freedland; Kirsten Lynn Greene; Lars Holmberg; Philip Kantoff; Badrinath R Konety; Mohammad Hassan Murad; David F Penson; Anthony L Zietman
Journal:  J Urol       Date:  2013-05-06       Impact factor: 7.450

3.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

Review 4.  The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer.

Authors:  Ariel A Schulman; Christina Sze; Efrat Tsivian; Rajan T Gupta; Judd W Moul; Thomas J Polascik
Journal:  Curr Urol Rep       Date:  2017-07       Impact factor: 3.092

Review 5.  Recent Changes in Prostate Cancer Screening Practices and Epidemiology.

Authors:  Daniel J Lee; Katherine Mallin; Amy J Graves; Sam S Chang; David F Penson; Matthew J Resnick; Daniel A Barocas
Journal:  J Urol       Date:  2017-05-25       Impact factor: 7.450

6.  Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.

Authors:  Carlotta Buzzoni; Anssi Auvinen; Monique J Roobol; Sigrid Carlsson; Sue M Moss; Donella Puliti; Harry J de Koning; Chris H Bangma; Louis J Denis; Maciej Kwiatkowski; Marcos Lujan; Vera Nelen; Alvaro Paez; Marco Randazzo; Xavier Rebillard; Teuvo L J Tammela; Arnauld Villers; Jonas Hugosson; Fritz H Schröder; Marco Zappa
Journal:  Eur Urol       Date:  2015-03-16       Impact factor: 20.096

7.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

8.  Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.

Authors:  Laurence Klotz; Danny Vesprini; Perakaa Sethukavalan; Vibhuti Jethava; Liying Zhang; Suneil Jain; Toshihiro Yamamoto; Alexandre Mamedov; Andrew Loblaw
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

Review 9.  Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?

Authors:  Kae Jack Tay; Melissa Mendez; Judd W Moul; Thomas J Polascik
Journal:  Curr Opin Urol       Date:  2015-05       Impact factor: 2.309

10.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.